Menu Back toPlenary Session 2: Patients as Partners - What’s in it for the Patient?

Clinical Trials and Data Science Conference


Plenary Session 2: Patients as Partners - What’s in it for the Patient?

Session Chair(s)

François  Houyez

François Houyez

  • Treatment Information and Access Director, Health Policy Advisor
  • European Organisation for Rare Diseases (EURORDIS), France
Álmath Máire Spooner, PhD, RPh

Álmath Máire Spooner, PhD, RPh

  • Director of Regulatory Policy and Intelligence
  • AbbVie, Ireland

Speaker(s)

Dominique  Hamerlijnck, MBA

Returning Individual Research Results to Trial Participants

Dominique Hamerlijnck, MBA

  • Patient Expert
  • Atini, Netherlands
Solange  Corriol-Rohou, DrMed, MD, PhD

Digitalisation as a Facilitator to Patient-Centric Development

Solange Corriol-Rohou, DrMed, MD, PhD

  • Senior Director, Global Regulatory Affairs & Policy, R&D, Europe
  • AstraZeneca , France
Rob  Camp

What’s in it for the patient?

Rob Camp

  • Director, International Patient Collaboration
  • EUPATI Spain, Spain
Maria  Mavris, PhD

Opportunities for Early Dialogue with Patients (Regulator Perspective)

Maria Mavris, PhD

  • Patient Relations
  • European Medicines Agency, Netherlands

Contact us

Registration Questions?

Send Email
+41 61 225 51 51